158 related articles for article (PubMed ID: 26333016)
1. Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Labenski M; Mastrandrea NJ; Canatsey RD; Monks TJ; Lau SS
Mol Carcinog; 2016 Aug; 55(8):1243-50. PubMed ID: 26333016
[TBL] [Abstract][Full Text] [Related]
2. ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Gard JM; Nagle RB; Dietrich JD; Monks TJ; Lau SS
Toxicol Sci; 2011 Nov; 124(1):75-87. PubMed ID: 21813464
[TBL] [Abstract][Full Text] [Related]
3. cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Tham KY; Mastrandrea NJ; Gallegos AC; Monks TJ; Lau SS
Toxicol Sci; 2011 Aug; 122(2):361-71. PubMed ID: 21693435
[TBL] [Abstract][Full Text] [Related]
4. Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis-2 tumor suppressor gene.
Yoon HS; Monks TJ; Walker CL; Lau SS
Mol Carcinog; 2001 May; 31(1):37-45. PubMed ID: 11398196
[TBL] [Abstract][Full Text] [Related]
5. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat.
Patel SK; Ma N; Monks TJ; Lau SS
Mol Carcinog; 2003 Nov; 38(3):141-54. PubMed ID: 14587099
[TBL] [Abstract][Full Text] [Related]
6. Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat.
Habib SL; Phan MN; Patel SK; Li D; Monks TJ; Lau SS
Carcinogenesis; 2003 Mar; 24(3):573-82. PubMed ID: 12663520
[TBL] [Abstract][Full Text] [Related]
7. Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone.
Lau SS; Monks TJ; Everitt JI; Kleymenova E; Walker CL
Chem Res Toxicol; 2001 Jan; 14(1):25-33. PubMed ID: 11170505
[TBL] [Abstract][Full Text] [Related]
8. Tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells.
Yoon HS; Ramachandiran S; Chacko MA; Monks TJ; Lau SS
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F417-24. PubMed ID: 14612383
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity.
Yoon HS; Monks TJ; Everitt JI; Walker CL; Lau SS
Am J Physiol Renal Physiol; 2002 Aug; 283(2):F262-70. PubMed ID: 12110509
[TBL] [Abstract][Full Text] [Related]
10. Induction of ERK1/2 and histone H3 phosphorylation within the outer stripe of the outer medulla of the Eker rat by 2,3,5-tris-(glutathion-S-yl)hydroquinone.
Dong J; Everitt JI; Lau SS; Monks TJ
Toxicol Sci; 2004 Aug; 80(2):350-7. PubMed ID: 15129024
[TBL] [Abstract][Full Text] [Related]
11. Tuberous sclerosis complex and DNA repair.
Habib SL
Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical analysis of quinol-thioether-derived covalent protein adducts in rodent species sensitive and resistant to quinol-thioether-mediated nephrotoxicity.
Kleiner HE; Jones TW; Monks TJ; Lau SS
Chem Res Toxicol; 1998 Nov; 11(11):1291-300. PubMed ID: 9815189
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
14. A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.
Tyburczy ME; Jozwiak S; Malinowska IA; Chekaluk Y; Pugh TJ; Wu CL; Nussbaum RL; Seepo S; Dzik T; Kotulska K; Kwiatkowski DJ
Hum Mol Genet; 2015 Apr; 24(7):1836-42. PubMed ID: 25432535
[TBL] [Abstract][Full Text] [Related]
15. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.
Bonsib SM; Boils C; Gokden N; Grignon D; Gu X; Higgins JP; Leroy X; McKenney JK; Nasr SH; Phillips C; Sangoi AR; Wilson J; Zhang PL
Pathol Res Pract; 2016 Nov; 212(11):972-979. PubMed ID: 27640314
[TBL] [Abstract][Full Text] [Related]
16. Determination of loss of heterozygosity in frozen and paraffin embedded tumors by denaturating high-performance liquid chromatography (DHPLC).
Kleymenova E; Walker CL
J Biochem Biophys Methods; 2001 Jan; 47(1-2):83-90. PubMed ID: 11179764
[TBL] [Abstract][Full Text] [Related]
17. The genetic basis of kidney cancer: why is tuberous sclerosis complex often overlooked?
Henske EP
Curr Mol Med; 2004 Dec; 4(8):825-31. PubMed ID: 15579029
[TBL] [Abstract][Full Text] [Related]
18. Tuberin haploinsufficiency is associated with the loss of OGG1 in rat kidney tumors.
Habib SL; Simone S; Barnes JJ; Abboud HE
Mol Cancer; 2008 Jan; 7():10. PubMed ID: 18218111
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity and cell-proliferation induced by the nephrocarcinogen hydroquinone and its nephrotoxic metabolite 2,3,5-(tris-glutathion-S-yl)hydroquinone.
Peters MM; Jones TW; Monks TJ; Lau SS
Carcinogenesis; 1997 Dec; 18(12):2393-401. PubMed ID: 9450487
[TBL] [Abstract][Full Text] [Related]
20. Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex.
Takahashi DK; Dinday MT; Barbaro NM; Baraban SC
Epilepsia; 2004 Dec; 45(12):1525-30. PubMed ID: 15571510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
